ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical companyBaselmetaLead Therapeutics AG
metaLead Therapeutics AG Logo
Verified· 3 sourcesTrust Score
Summary

About the company

metaLead Therapeutics AG develops medicines for metal-related diseases. The company researches chelation therapies designed to target toxic or dysregulated metals, including in Wilson disease and lead poisoning.

AI-generated
Presence

Service area

Offering

Products & services

Industry:
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
3.8/5

metaLead Therapeutics AG

Pharmaceutical company
✓ Offered1
Drug development for metal-related diseases
Development of safe and effective medicines for metal-related diseases, with a focus on chelation therapy, selective metal binding, and oral, stably modified candidates.
Trust & reputation

ranQ Trust Score of metaLead Therapeutics AG: 3.8 out of 5.0

Trust Score3.8/ 5.0

High

x

Data basis 58% · As of November 2026

metaLead Therapeutics AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
metaLead Therapeutics AG scores 64.1 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.50.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
metaLead Therapeutics AG scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
metaLead Therapeutics AG scores 20.2 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.17.14%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.23.34%
Qualifications+0.00

metaLead Therapeutics AG reaches a ranQ Trust Score of 3.8 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

May 6, 2025Media
metaLead secures CHF 1 million to tackle metal poisoning
startupticker.ch
March 10, 2023Media
CHF 150,000 to develop antidotes against toxic metals
startupticker.ch

Knowledge

No knowledge articles yet

Once metaLead Therapeutics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

metaLead Therapeutics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank metaLead Therapeutics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of metaLead Therapeutics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hochbergerstrasse 60c
4057 Basel

At a glance

Legal form
Corporation
UID
CHE-306.518.202
Founded
2023 · 3 years
Last commercial register change
June 8, 2026
Employees
1 to 10

Active in 1 of 26 cantons

  • BSBasel-City
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
  • Full methodology

    Similar companies

    VA
    Versameb AG
    Basel
    ST
    Stromal Therapeutics AG
    Basel
    AP
    Acadia Pharmaceuticals GmbH
    Basel
    HP
    Hengrui Pharmaceuticals Europe AG
    Basel
    AS
    Azafaros Switzerland AG
    Basel
    AP
    Arakena Pharmaceuticals AG
    Basel
    IP
    Ironwood Pharmaceuticals GmbH
    Basel
    RS
    Roivant Sciences GmbH
    Basel